Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS) Meeting Abstract
| Authors: | Tabernero, J.; Shitara, K.; Dvorkin, M.; Mansoor, W.; Arkenau, H. T.; Prokharau, A.; Alsina, M.; Ghidini, M.; Faustino, C.; Gorbunova, V.; Zhavrid, E.; Nishikawa, K.; Hosokawa, A.; Ganea, D.; Yalçin, Ş.; Fujitani, K.; Beretta, G.; Winkler, R.; Makris, L.; Doi, T.; Ilson, D. |
| Abstract Title: | Overall survival results from a phase III trial of trifluridine/tipiracil versus placebo in patients with metastatic gastric cancer refractory to standard therapies (TAGS) |
| Meeting Title: | ESMO 20th World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2018 Jun 20-23 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-06-01 |
| Start Page: | mdy208.001 |
| Language: | English |
| ACCESSION: | WOS:000439970900359 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy208.001 |
| Notes: | Meeting Abstract: LBA-002 -- Appears on page 122 of the abstract book -- Source: Wos |
